Research
Hormonal
Tirzepatide and cagrilintide-semaglutide are promising agents for adjunctive pharmacological management of weight gain in SMI.
Practitioners should consider these new agents as potential options for managing weight gain in SMI patients.
StrongSupportsmedium confidence
This review identified tirzepatide and cagrilintide-semaglutide among others as promising agents for adjunctive pharmacological management of weight gain.
Why this rating
The claim is based on emerging research findings.
Source
Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review
Riddhita De et al. · Expert Opinion on Pharmacotherapy · 2023
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →